BRCA2 and neoplasm: In our BRCA2 –mutated xenograft, we did not observe an increased phosphorylation of ERK nor a decreased in BRCA1 gene expression after mTOR inhibition, indicating that this mechanism is not involved in the anti-tumor effect of olaparib and everolimus combination.